Comment on

• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.

  Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R. Ledergerber B, et al. Lancet. 1999 Mar 13;353(9156):863-8. doi: 10.1016/s0140-6736(99)01122-8. Lancet. 1999. PMID: 10093977
• Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

  Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE. Wiktor SZ, et al. Lancet. 1999 Mar 6;353(9155):781-5. doi: 10.1016/S0140-6736(98)10412-9. Lancet. 1999. PMID: 10459958 Clinical Trial.
• Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.

  Wood E, Braitstein P, Montaner JS, Schechter MT, Tyndall MW, O'Shaughnessy MV, Hogg RS. Wood E, et al. Lancet. 2000 Jun 17;355(9221):2095-100. doi: 10.1016/S0140-6736(00)02375-8. Lancet. 2000. PMID: 10902622
• Defining and refining international donor support for combating the AIDS pandemic.

  Attaran A, Sachs J. Attaran A, et al. Lancet. 2001 Jan 6;357(9249):57-61. doi: 10.1016/S0140-6736(00)03576-5. Lancet. 2001. PMID: 11197373